T1	Participants 580 652	opioid-tolerant male and female patients (aged > or =17 years) with BTcP
T2	Participants 1237 1297	patients entered a long-term safety phase of up to 12 months
T3	Participants 1412 1452	131 patients entered the titration phase
T4	Participants 1884 1963	Patient recruitment was stopped early, due to positive interim analysis results
